MyoCon! Rate increases on August 28th!
Promising Trial News from argenx and Abcuro The myositis community recently received encouraging news from two companies developing treatments for different forms of myositis. While much work remains before these…
Continue Reading
From Volcanic Soil to a Possible Treatment for IBM
By Nataliya Slater Our team in Australia is leading a clinical trial investigating sirolimus (rapamycin) as a potential treatment for inclusion body myositis (IBM). But do you know the remarkable…
Continue Reading
Seven Voices from the Myositis Community
The Myositis Association and Community Resonance Foundation Publish Myositis Issue of ENCORES Belfast, ME – August 2026 – What happens when a disease is difficult to recognize, difficult to diagnose,…
Continue Reading
Inflammation May Affect Mood
Children and teens living with idiopathic inflammatory myopathies (IIM)—including juvenile dermatomyositis (JDM)—often face more than muscle weakness, fatigue, and skin symptoms. Many also struggle with mental health challenges, such as…
Continue Reading
Going the Distance for Dermatomyositis: Trail Update from the PCT
By Kaila Balch When I launched this journey in May, my goal was simple: hike the Pacific Crest Trail in honor of my cousin Brandon, who lives with dermatomyositis, while…
Continue Reading